[On-Demand Webinar] Reconstructing the Rare Disease Paradigm

Rethinking recruitment strategies for rare disease clinical trials

February 14, 2019 | Eteri Tsetskhladze, MD, PhD, FESC, FACC

Rare cardiovascular diseases are on the rise. In fact, there’s a 1 in 10 chance you know someone with a rare disease. Now more than ever, it’s important to throttle the recruitment and retention obstacles in rare disease clinical trials to enable new treatments for this growing patient population.

Eteri Tsetskhladze, MD, PhD, FESC, FACC
MEET THE AUTHOR

Eteri Tsetskhladze, MD, PhD, FESC, FACC

Vice President, General Medicine Medical Lead, Medical Affairs
LEARN MORE